| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $322.8M | — | +4.3% |
| Cost of Revenue | $204.6M | — | +1.3% |
| Gross Profit | $118.2M | — | +9.8% |
| R&D Expense | $13.6M | — | +6.8% |
| SG&A Expense | $74.0M | — | +4.2% |
| Operating Income | $30.9M | — | +30.8% |
| Pre-tax Income | $32.2M | — | +29.8% |
| Income Tax | $8.1M | — | +28.1% |
| Net Income | $22.4M | — | +29.6% |
| EPS (Basic) | $0.89 | — | +30.9% |
| EPS (Diluted) | $0.89 | — | +30.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $189.3M | -16.4% | +27.9% |
| Accounts Receivable | $42.6M | -5.3% | +2.4% |
| Current Assets | $550.5M | +5.8% | +27.5% |
| Total Assets | $654.9M | +4.6% | +18.1% |
| Current Liabilities | $305.4M | +4.2% | +13.2% |
| Total Liabilities | $307.3M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.1M | — | -6282.3% |
| Capital Expenditures | $5.8M | — | +10.3% |
| Investing Cash Flow | -$9.2M | — | -5.2% |
| Financing Cash Flow | -$9.2M | — | -148.3% |
| Free Cash Flow | -$16.0M | — | -212.1% |
| +12.8% |
| Stockholders' Equity | $320.7M | +5.1% | +23.1% |